Primary cilia control endothelial permeability by regulating expression and location of junction proteins.

Endothelial permeability Intercellular junctions Intracranial aneurysm Primary cilium Wall shear stress

Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
06 05 2022
Historique:
received: 18 06 2020
accepted: 09 05 2021
pubmed: 12 5 2021
medline: 11 5 2022
entrez: 11 5 2021
Statut: ppublish

Résumé

Wall shear stress (WSS) determines intracranial aneurysm (IA) development. Polycystic kidney disease (PKD) patients have a high IA incidence and risk of rupture. Dysfunction/absence of primary cilia in PKD endothelial cells (ECs) may impair mechano-transduction of WSS and favour vascular disorders. The molecular links between primary cilia dysfunction and IAs are unknown. Wild-type and primary cilia-deficient Tg737orpk/orpk arterial ECs were submitted to physiological (30 dynes/cm2) or aneurysmal (2 dynes/cm2) WSS, and unbiased transcriptomics were performed. Tg737orpk/orpk ECs displayed a fivefold increase in the number of WSS-responsive genes compared to wild-type cells. Moreover, we observed a lower trans-endothelial resistance and a higher endothelial permeability, which correlated with disorganized intercellular junctions in Tg737orpk/orpk cells. We identified ZO-1 as a central regulator of primary cilia-dependent endothelial junction integrity. Finally, clinical and histological characteristics of IAs from non-PKD and PKD patients were analysed. IAs in PKD patients were more frequently located in the middle cerebral artery (MCA) territory than in non-PKD patients. IA domes from the MCA of PKD patients appeared thinner with less collagen and reduced endothelial ZO-1 compared with IA domes from non-PKD patients. Primary cilia dampen the endothelial response to aneurysmal low WSS. In absence of primary cilia, ZO-1 expression levels are reduced, which disorganizes intercellular junctions resulting in increased endothelial permeability. This altered endothelial function may not only contribute to the severity of IA disease observed in PKD patients, but may also serve as a potential diagnostic tool to determine the vulnerability of IAs.

Identifiants

pubmed: 33974072
pii: 6273663
doi: 10.1093/cvr/cvab165
pmc: PMC9074981
doi:

Substances chimiques

Tumor Suppressor Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1583-1596

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Ann N Y Acad Sci. 2009 May;1165:113-20
pubmed: 19538295
Cytoskeleton (Hoboken). 2013 Jan;70(1):24-31
pubmed: 23124988
Bioscience. 2014 Dec 1;64(12):1126-1137
pubmed: 25960570
Stroke. 2018 Mar;49(3):780-787
pubmed: 29437983
Eur Heart J. 2014 Nov 14;35(43):3013-20, 3020a-3020d
pubmed: 25230814
Stroke. 2004 Oct;35(10):2287-93
pubmed: 15322297
J Cell Biol. 2018 Aug 6;217(8):2813-2830
pubmed: 29858212
J Mol Cell Cardiol. 2012 Aug;53(2):299-309
pubmed: 22659288
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
J Cell Biol. 1986 Dec;103(6 Pt 2):2787-96
pubmed: 3539945
J Neurointerv Surg. 2019 Nov;11(11):1105-1112
pubmed: 31337731
J Cell Biol. 2015 Mar 16;208(6):821-38
pubmed: 25753039
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Physiol Rev. 2004 Jul;84(3):869-901
pubmed: 15269339
J Clin Invest. 2015 Oct 1;125(10):3861-77
pubmed: 26389677
World Neurosurg. 2018 Sep;117:453-458.e1
pubmed: 29902602
Neurosurg Focus. 2019 Jul 1;47(1):E21
pubmed: 31261126
AJNR Am J Neuroradiol. 2014 Jul;35(7):1254-62
pubmed: 23598838
Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1151-1160
pubmed: 31362991
J Neuropathol Exp Neurol. 2018 Jul 1;77(7):555-566
pubmed: 29688417
Nat Rev Mol Cell Biol. 2004 Apr;5(4):261-70
pubmed: 15071551
Acad Radiol. 2019 May;26(5):664-673
pubmed: 29908979
Circulation. 2008 Mar 4;117(9):1161-71
pubmed: 18285569
N Engl J Med. 2006 Aug 31;355(9):928-39
pubmed: 16943405
Circulation. 2007 Dec 11;116(24):2830-40
pubmed: 18025535
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10779-84
pubmed: 8855257
Atherosclerosis. 2008 Feb;196(2):542-50
pubmed: 17631294
J Cell Biol. 1993 May;121(3):491-502
pubmed: 8486731
Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):616-27
pubmed: 25633317
Am J Physiol Cell Physiol. 2014 Aug 1;307(3):C245-54
pubmed: 24920678
Eur J Clin Invest. 2018 Sep;48(9):e12992
pubmed: 29962043
Neurosurgery. 2013 Mar;72(3):492-6; discussion 496
pubmed: 23151622
Circ Res. 2011 Apr 29;108(9):1093-101
pubmed: 21393577
Semin Cell Dev Biol. 2014 Dec;36:213-23
pubmed: 25152334
Mol Biol Cell. 2005 Dec;16(12):5686-98
pubmed: 16195341
Shock. 2018 May;49(5):604-611
pubmed: 28800037
Cleve Clin J Med. 2017 Jun;84(6):471-481
pubmed: 28628430
Oncogene. 2007 Feb 22;26(8):1222-30
pubmed: 16924233
J Biol Chem. 2015 Jul 3;290(27):16595-606
pubmed: 26023235

Auteurs

Mannekomba R Diagbouga (MR)

Department of Pathology and Immunology, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.

Sandrine Morel (S)

Department of Pathology and Immunology, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.
Neurosurgery Division, Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Rue Gabrielle-Perret-Gentil 4, CH-1211 Geneva, Switzerland.

Anne F Cayron (AF)

Department of Pathology and Immunology, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.

Julien Haemmerli (J)

Neurosurgery Division, Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Rue Gabrielle-Perret-Gentil 4, CH-1211 Geneva, Switzerland.

Marc Georges (M)

Neurosurgery Division, Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Rue Gabrielle-Perret-Gentil 4, CH-1211 Geneva, Switzerland.

Beerend P Hierck (BP)

Department of Anatomy and Embryology, Leiden University Medical Center, Eindhovenweg 20, 2333ZC Leiden, the Netherlands.

Eric Allémann (E)

School of Pharmaceutical Sciences, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.
Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.

Sylvain Lemeille (S)

Department of Pathology and Immunology, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.

Philippe Bijlenga (P)

Neurosurgery Division, Department of Clinical Neurosciences, Geneva University Hospitals and University of Geneva, Rue Gabrielle-Perret-Gentil 4, CH-1211 Geneva, Switzerland.

Brenda R Kwak (BR)

Department of Pathology and Immunology, University of Geneva, Rue Michel-Servet 1, CH-1211 Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH